Substance / Medication

Gonadorelin

Overview

Active Ingredient
gonadorelin
RxNorm CUI
6384

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Effect of 200 µg of gonadorelin at the first gonadotropin-releasing hormone of the Resynch-25 on ovarian dynamics and fertility in lactating Holstein cows.
Leão Iago M R, El Azzi Marcelo S, Anta-Galván Everaldo et al. · J Dairy Sci · 2024
PMID: 38101731Observational
Effect of gonadorelin, lecirelin, and buserelin on LH surge, ovulation, and progesterone in cattle.
Picard-Hagen N, Lhermie G, Florentin S et al. · Theriogenology · 2015
PMID: 25890780Observational
Advances and perspectives in the analytical technology for small peptide hormones analysis: A glimpse to gonadorelin.
Torrini Francesca, Scarano Simona, Palladino Pasquale et al. · J Pharm Biomed Anal · 2023
PMID: 36858006Case Report
Anaphylaxis to gonadorelin acetate in a girl with central precocious puberty.
Akın Onur, Yavuz Süleyman Tolga, Hacıhamdioğlu Bülent et al. · J Pediatr Endocrinol Metab · 2015
PMID: 26197466Case Report
Side effects of pharmacotherapy on bone with long-acting gonadorelin agonist triptorelin for paraphilia.
Hoogeveen John, Van der Veer Eveline · J Sex Med · 2008
PMID: 17971105Case Report
[Side effects of treatment with the long-acting gonadorelin agonist triptorelin in a case of paraphilia].
Hoogeveen J H, van der Veer E · Tijdschr Psychiatr · 2007
PMID: 17290340Case Report

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Gonadorelin (substance)
SNOMED CT
397197007
UMLS CUI
C0023610
RxNorm CUI
6384

Clinical Data

This intervention maps to 4 entities in the Healos knowledge graph.

4
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.